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Catalyst for innovation
A renovated telephone factory adds a prime St. Louis 
location to commercialize research technology, a place 
where students and trainees can engage creatively with 
businesspeople and investors in biomedicine. This office 
and lab facility at 4240 Duncan Ave., dubbed @4240, 
provides space for established and start-up companies.
The Office of the Vice Chancellor for Research and other 
university tenants anchor this new $73-million facility, 
located in the CORTEX bioscience district just east of 
Washington University Medical Center. 
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ew findings may help explain why 
millions of malnourished children 
suffer from stunted growth and fail 
to thrive after treatment with nutrient-rich 
therapeutic foods.
Studying healthy and malnourished young 
children in Bangladesh, a team at the School 
of Medicine found that malnutrition has per-
sistent detrimental effects on the vast com-
munity of microbes living in the gut. These 
“friendly” microbes typically aid in extracting 
nutrients and calories from food, and perform 
many other vital functions.
The results suggest that the long-term 
consequences of childhood malnutrition, such 
as stunted growth, cognitive problems and 
weakened immune systems, may be rooted in 
lingering, underdeveloped gut microbes that 
can’t fully harvest energy and calories from 
food, said senior author Jeffrey I. Gordon, MD, 
director of Washington University’s Center for 
Genome Sciences & Systems Biology. 
In healthy children, the researchers identi-
fied features associated with normal develop-
ment of the gut’s community of microbes. In 
comparison, they noted that malnourished 
children carried communities of gut microbes 
that did not mature along a normal trajectory. 
These immature bacterial collections could 
not be restored to good health with standard 
treatments of therapeutic foods. 
The research, conducted in collaboration 
with colleagues at the International Centre for 
Diarrhoeal Disease Research in Dhaka, 
Bangladesh, is published online in Nature. 
“Although therapeutic food-based interven-
tions have resulted in a significant decline in 
deaths from malnutrition, many children never 
fully recover,” said first author Sathish 
Subramanian, a Washington University MD/
PhD student. “We found that children who 
were malnourished had gut microbial commu-
nities that were not consistent with their 
chronological ages. The severity of a child’s 
malnourishment was tied closely with the 
degree of immaturity of his or her gut micro-
bial community, and this immaturity could not 
be durably repaired with standard treatments.”
The researchers are following up their 
research in animal models colonized with 
immature gut microbe communities from mal-
nourished children. They are seeking to deter-
mine whether giving therapeutic foods for 
longer periods of time or administering benefi-
cial mixtures of naturally occurring human gut 
microbes can repair this immaturity and 
improve health.




These immature bacterial 
collections could not 
be restored to good 
health with food-based 
interventions.
A Bangladeshi 
mother holds her 
malnourished child. 
The dark spot placed 
on his head is said to 
ward off evil spirits.
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School of Medicine researchers have received an $8 million 
grant to investigate the genetic and environmental roots  
of cardiovascular disease risk factors. e four-year grant  
supports the rst large-scale, multiethnic statistical analysis  
of risk factors for cardiovascular disease that looks at  
lifestyle interactions with genes.
e investigators will use existing data from more than  
30 studies, which include detailed genetic data, measures  
of cardiovascular risk factors — namely, blood pressure  
and cholesterol levels — as well as information on lifestyle, 
including smoking, alcohol consumption, physical activity, 
socioeconomic status and diet.
To carry out this type of study, large numbers of subjects 
are needed to have sucient power to detect interactions of 
genes and lifestyle.
e study represents a massive international collaboration 
that brings together data on more than 300,000 subjects from 
diverse ethnicities. e multiethnic approach allows a broad 
view of interactions and how they play out in populations 
with dierent genetic and cultural histories.
“is study is unprecedented in many ways,” said principal 
investigator D.C. Rao, PhD, professor of biostatistics, genetics, 
psychiatry and mathematics and director of the Division of 
Biostatistics. 
“We have compelling preliminary data that highlight the 
potential of these investigations,” he said. “We found, for 
example, several novel genes associated with high blood pres-
sure that were not previously known until the interactions 
with alcohol consumption or education were brought in.”
Considering lifestyle factors in the context of a genetic 
analysis oers the possibility of identifying novel genes and 







Earhart named PT program director
Gammon Earhart, PhD, professor of physical therapy, now 
is director of the Program in Physical erapy at the School 
of Medicine. She succeeds Susie Deusinger, PhD, who has 
retired.
Larry J. Shapiro, MD, executive vice chan-
cellor for medical aairs and dean of the 
medical school, announced the appointment.
“Gammon Earhart is an innovative 
thinker, a well-respected researcher and a 
leader in physical therapy,” Shapiro said. 
“She is exceptionally qualied to continue 
the legacy of excellence Susie Deusinger built 
during her 24 years as director.”
Earhart, also a professor of neurobiology 
and of neurology, joined the faculty in 2004. 
A 2000 graduate of the Movement Science 
PhD Program, she is associate director of that program. 
Earhart earned undergraduate and master’s degrees from 
Arcadia University in Pennsylvania and did postdoctoral 
work at Oregon Health and Science University.
Earhart’s research focuses on nervous system control of 
movement and examines how dierent treatment approaches 
may benet people with Parkinson’s disease. 
Under Deusinger’s leadership, the program evolved into 
one of the top programs in the country and consistently 
ranks among the best, according to U.S. News & World Report. 
How gene-lifestyle interactions 
affect cardiovascular disease





























Problem affecting millions of children may be rooted in underdeveloped gut communities
Gammon Earhart, PhD
Investigators Ingrid 
Borecki, PhD, and  
D.C. Rao, PhD
Uncommon monkey  Researchers at The Genome 
Institute at Washington University and at Baylor College of Medicine 
have decoded the genome of the common marmoset.  A look at 
its DNA begins to explain the animal’s frequent twin births; most 
primate species have single births. Unlike humans, marmosets consis-
tently give birth to twins without any medical issues. Marmoset gene 
changes associated with twinning perhaps act as a critical switch 
between multiple and single pregnancies. Findings could shed light 
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Ralph J. Damiano Jr., MD, an internationally known car-
diac surgeon, has been named chief of the Division of 
Cardiothoracic Surgery at the School of Medicine.
e new appointment is one of several taking eect in the 
cardiothoracic surgery division. With 
his appointment, Damiano becomes 
the Evarts Ambrose Graham Professor 
of Surgery. He succeeds G. Alexander 
Patterson, MD, who has served as chief of 
cardiothoracic surgery since 2005.
Patterson, who becomes the Joseph 
C. Bancro Professor of Cardiothoracic 
Surgery, has stepped down as division 
chief to devote more time to editing e 
Annals of oracic Surgery, the journal 
of e Society of oracic Surgeons. He 
is editor-elect of the journal and will become editor-in-chief 
early next year.
Marc Moon, MD, succeeds Damiano as chief of the 
Section of Cardiac Surgery. 
“We have tremendous depth and breadth in the Division 
of Cardiothoracic Surgery,” said Timothy J. Eberlein, MD, the 
Bixby Professor and chairman of the Department of Surgery, 
in announcing the new appointments. “Our cardiothoracic 
surgeons are national and international leaders in developing 
and rening innovative surgical procedures for the heart and 
for pulmonary diseases. We are grateful to Alec Patterson for 
his many years of dedicated service in leading the division to 
additional prominence and look forward to Ralph Damiano 
continuing the long tradition of leadership in the eld.”







Senior prom Johanna Kaufman, medical student and leader 
of the Geriatrics Outreach Group, dances with Don Harper. Harper 
was one of about 200 St. Louis-area seniors who attended the annual 
prom in the 560 Music Building. The event fosters intergenerational 
dialogue, social interaction for seniors and is a learning opportunity 
for students.  The prom is hosted by student volunteers from the 
medical school, the programs in Physical Therapy and Occupational 
Therapy and the undergraduate schools.
A new center will help scientists use the power of the 
immune system to ght infections and cancers. 
e Center for Human Immunology and Immunotherapy 
Programs (CHiiPs) is part of BioMed21, the university’s ini-
tiative to accelerate basic science discoveries into improved 
diagnosis and treatment for patients. e center is housed in 
the BJC Institute of Health at Washington University.
Scientists also are developing ways to restrain the 
immune system when it mistakenly attacks healthy tissue, 
leading to autoimmune disorders. 
“Several very important basic discoveries in these areas 
have been made by Washington University faculty, but it has 
been challenging to move those discoveries into the clinic,” 
said CHiiPs director Robert D. Schreiber, PhD, the Alumni 
Professor of Pathology and Immunology.
Pioneering researchers at the medical school have shown 
that the immune system can recognize cancers and regulate 
their growth. e scientists also have identied ways to 
manipulate the immune system’s ability to destroy cancer 
cells. e school has been a leader in developing vaccines for 
emergent diseases such as West Nile virus and in identifying 
cells and molecules involved in autoimmune conditions.
A center laboratory will monitor changes in the immune 
system during clinical trials of new immunotherapies.
“Until now, faculty performing immunological clinical 
trials or studying unique immunologic clinical syndromes 
had to set up these tests in their own labs, which is a lot of 
work and doesn’t always produce standardized results,” 
Schreiber said.
e center’s leaders are recruiting faculty interested in 
applying immunological discoveries to clinical problems. 
New center aims to use immune 
system to fight cancer, diseases
The center’s new time-of-flight mass cytometer simultaneously detects more 
than 50 different structures either on the cell surface or inside the cell, provid-
ing important clues to the identity of the cells and the functions they perform.  
From left, center leaders Olga Malkova, PhD; Stephen Oh, MD, PhD; Michael 
Diamond, MD, PhD; Robert Schreiber, PhD; and Wayne Yokoyama, MD.
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cientists have advanced a brain-
scanning technology that tracks what 
the brain is doing by shining dozens 
of tiny LED lights on the head. This new gen-
eration of neuroimaging compares favorably, 
while avoiding the radiation exposure and 
bulky magnets other approaches require, 
according to School of Medicine research. 
The new optical approach to brain scan-
ning is ideally suited for children and for 
patients with electronic implants, such as 
pacemakers, cochlear implants and deep brain 
stimulators (used to treat Parkinson’s disease). 
The magnetic fields in magnetic resonance 
imaging (MRI) often disrupt either the func-
tion or safety of implanted electrical devices, 
whereas there is no interference with the opti-
cal technique. 
The new technology is called diffuse opti-
cal tomography (DOT). While researchers have 
been developing it for more than 10 years, 
the method had been limited to small regions 
of the brain. The new DOT instrument covers 
two-thirds of the head and for the first time 
can image brain processes taking place in 
e next generation of brain scanning
S
R A D I O L O G Y  R E S E A R C H
multiple regions and brain networks such as 
those involved in language processing and 
self-reflection (daydreaming). 
“When the neuronal activity of a region in 
the brain increases, highly oxygenated blood 
flows to the parts of the brain doing more 
work, and we can detect that,” said senior 
author Joseph Culver, PhD, associate professor 
of radiology. “It’s roughly akin to spotting the 
rush of blood to someone’s cheeks when  
they blush.”
The technique works by detecting light 
transmitted through the head and capturing 
the dynamic changes in the colors of the  
brain tissue. 
Although DOT technology now is used in 
research settings, it has the potential to be 
helpful in many medical scenarios as a sur-
rogate for functional MRI, the most commonly 
used imaging method for mapping human 
brain function. Functional MRI also tracks 
activity in the brain via changes in blood flow. 
Another common method for mapping 
brain function is positron emission tomog-
raphy (PET), which involves radiation expo-
sure. Because DOT technology does not use 
radiation, multiple scans performed over time 
could be used to monitor patients treated for 
brain injuries, developmental disorders such 
as autism, neurodegenerative disorders such 
as Parkinson’s, and other diseases. 
Unlike fMRI and PET, DOT technology is 
designed to be portable, so it could be used at 
a patient’s bedside or in the operating room. 
While DOT doesn’t let scientists peer very 
deeply into the brain, researchers can get reli-
able data to a depth of about one centimeter 
of tissue. That centimeter contains some of the 
brain’s most important and interesting areas 




The first phase of Ballpark Village, a mixed-use 
entertainment and retail district next door to Busch 
Stadium in St. Louis, opened for this year’s baseball 
season. But, in the 1870s, this area was the epicenter 
of medical education in St. Louis — home to the two 


























Missouri Medical College and St. Louis Medical 
College. These two colleges later would merge to 
become Washington University School of Medicine. 
To see maps, photos and learn more about these 
historical roots, visit bit.ly/1pu2xPx.
St. Louis Medical College in the 1870s
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School of Medicine researchers are leading a multi-insti-
tutional campaign to harness a newly recognized cellular 
defense against infection.
e project could lead to drugs with unprecedented ver-
satility in ghting dierent infections. A $32 million grant 
from the National Institutes of Health (NIH) is funding the 
collaborative, which also includes Massachusetts General 
Hospital, the Broad Institute and the University of Texas 
Southwestern Medical Center. 
e grant creates a four-site Center for Excellence 
in Translational Research (CETR), which is a National 
Institutes of Allergy and Infectious  
Diseases program.
“If we’re successful, we 
may develop drugs that 
allow us to treat bacte-
ria, viruses, fungi and 
parasites with a single 
medication,” said 
principal investigator 
Herbert W. Virgin IV, 
MD, PhD, head of the 
university’s Department 
of Pathology and 
Immunology. “We now 
have drugs that can take on 
viruses or bacteria but noth-
ing that can ght several 
types of infectious agents at 
the same time.”
Virgin and his colleagues 
are investigating a newly recognized connection between 
a cellular waste disposal system called autophagy and the 
body’s ability to fend o infections.
Scientists already knew that autophagy proteins clean out 
cellular debris. But researchers recently have started to link 
the proteins to infection control, suggesting that the disposal 
system may not only take out the trash but also help identify 
unwanted cellular houseguests — such as bacteria, viruses, 
fungi or parasites — and destroy them. 
Other proteins involved in autophagy may ght infection 
in dierent ways, indicating that this pathway is a versatile 
tool used by the body to ght a range of infections.
e researchers will identify proteins involved in autoph-
agy, explore the roles the proteins play in waste disposal and 
immunity, and attempt to develop drugs that engage the 
autophagy process in ghting infections.
Could a single medication fight 
multiple infectious agents?
$32 million NIH grant will fund project
e resources required to get discoveries from bench to bed-
side can be astounding. Many promising innovations never 
reach their potential.
To reverse this trend, e Avon Foundation for Women, 
the National Cancer Institute (NCI) and the Center for 
Advancing Innovation created the Breast Cancer Startup 
Challenge. e initiative was aimed at bringing 10 promising 
breast cancer discoveries out of the lab and closer to market.
Some 200 teams of graduate students worldwide com-
peted. Graduate students Hirak Biswas and Anurag Agarwal 
in the Division of Biology and Biomedical Sciences and 
Whitney Grither in the Medical Scientist Training Program 
won for their proposal to advance a therapeutic breast cancer 
vaccine developed by NCI researchers and patented in 2011.
e team also included Gurudatta Begur Nadiger, an execu-
tive MBA student at Northwestern University, and Erik Nyre, 
a law student at the University of Minnesota.
e vaccine showed promise in preclinical mouse trials, 
but further research and development is needed. is  
would be the focus of the startup company. e team  
must negotiate an exclusive licensing agreement with the 
NCI’s technology transfer oce and raise seed funding. 
School of Medicine faculty members mentored the students.
Breast cancer startup challenge
 
Using a newly recognized 
cellular defense system  
to fight infection
Look for
Neuro thriller  Neurosurgeon Eric 
Leuthardt’s research often has been described 
as science fiction brought to life. An associate 
professor of neurosurgery and of biomedi-
cal engineering, Leuthardt, MD, is working to 
develop brain implants known as neuropros-
thetics that detect brain signals and relay them 
to a computer. He hopes to use the technology 
to restore movement, speech and other func-
tions in people suffering from stroke. 
Experiences in the lab and the operating room 
inspired him to write a futuristic thriller. His 
first novel, “RedDevil 4,” envisions a world where brain implants 
permeate every level of personal and social interaction as cell-
phones do today. 
6  Washington University School of Medicine
Winning graduate students Hirak Biswas, Whitney Grither and Anurag Agarwal.
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hirteen-year-old Sydney Kendall had 
one request for the students building 
her robotic prosthetic arm: Make it pink.
Kendall Gretsch, Henry Lather and Kranti 
Peddada, 2014 seniors studying biomedical 
engineering in the School of Engineering & 
Applied Science, accomplished that and more, 
with guidance from School of Medicine faculty.
Using a 3-D printer,  
they created a robotic pros-
thetic arm out of bright-
pink plastic. Total cost: 
$200, a fraction of the price 
of standard prosthetics, 
which start at $6,000.
“Currently, prosthetics 
are very expensive, and 
because kids keep growing, 
it is too costly for them to 
have the latest technology,” 
said Sydney’s mother,  
Beth Kendall. 
While 3-D printers can 
cost about $2,500, they are 
capable of producing artificial limbs at a  
relatively low individual cost.
Sydney lost her arm in a boating accident 
at age 6. She learned to write with her left 
hand, but found most tasks difficult to accom-
plish with her prosthetic arm. Sydney said  
her new arm is easy to manipulate. By moving 
her shoulder, she can direct the arm to  
throw a ball, move a computer mouse and  
perform other tasks.
The students developed the robotic hand 
as part of an engineering design course with 
Joseph Klaesner, PhD, associate professor of 
physical therapy at the medical school. Charles 
A. Goldfarb, MD, and Lindley Wall, MD, ortho-
pedic hand surgeons and associate professors 
of orthopaedic surgery, served as mentors.
“They brought their engineering exper-
tise, and we shared our practical experience 
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minted MDs formally begin introducing themselves as “doctors.”
Despite years of preparation, it’s a steep learning curve —  
going from student, observer and helper, to being an on-call resident, 
writing orders and managing high-acuity patients through long nights.
Given significant changes in U.S. residency training — and 
reduction of hospital duty hours — residents are facing new 
challenges. Nationally, medical schools are thinking beyond the  
four-year experience and trying to offer more seamless transitions  
to residency. To help graduating students hit the ground running, 
School of Medicine faculty created “Capstone,” a four-week,  
robust hands-on course. 
“We are convinced it  
makes an impact at the outset  
of internship,” said course co- 
founder L. Michael Brunt, MD, 
professor of surgery. “This is an 
important first step leading to 
more specialized curriculum 
development that will better 
prepare our students for 
residency training.”
Through morning didactic sessions and 
afternoon procedure workshops, students cover 
many of the situations they soon will encounter  
in real life. Theoretical lectures are replaced  
with practical application, taking students’ accumulated knowledge  
— from first-year anatomy to third-year clerkships — and putting  
it all together. 
Here, they begin thinking like independent physicians, focusing 
on day-to-day tasks and in-the-moment decision-making, such as 
juggling multiple patients or choosing the right medication dosages. 
The students refine technical skills — suturing, placing a central 
intravenous line, or inserting a chest tube — procedures that, in  
some cases, they’ve only observed. Specialty-specific breakout  
sessions further reinforce essential clinical competencies. 
Paving the  
      road to
E
Theory put into practice: 
facilitators L. Michael 
Brunt, MD, Julie 
Woodhouse and  
Thomas M. De Fer, MD 
P H O T O S  B Y
R O B E R T  B O S T O N
8  Washington University School of Medicine Autumn 2014
v e r y  s u m m e r,  at teaching hospitals across the country, newly
Capstone course  
builds confidence  
in critical decision-  
making, hones  
hands-on skills of 
tomorrow’s physicians
R E S I D E N C Y
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Students practice inserting 
chest tubes into racks of 
ribs. This procedure is  
used in patients with  
a pneumothorax  
(collapsed lung).
R E S I D E N C Y
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A P S T O N E ,  created three years ago as a 
two-week elective by Brunt and Thomas M.  
De Fer, MD, professor of medicine, continues to 
evolve based on student and faculty feedback. 
“Capstone provides a ‘just-in-time’ learning 
experience for medical students who are a few 
months away from being an intern,” DeFer said. 
“That’s always been anxiety-provoking, but, 
until courses like this, it was just something 
that they had to work through as best as 
they could and hopefully not make too many 
mistakes along the way.
“Our students do get a lot of these 
educational elements earlier in the curriculum,  
but it’s always a challenge to retain it all.  
This course provides practical information in 
one fell swoop at a time when they need it  
the most and are most receptive.”
A s  p a r t  o f  t h e  co re  c u r r i c u l u m  in 
2014 –15, the four-week session will run twice, 
with each of the many procedural workshops 
offered multiple times, to accommodate the 
entire medical class. Hundreds of faculty and 
house staff members from many disciplines  
are involved in the program. Coordination is  
a year-round logistical challenge headed by  
Julie Woodhouse, assistant director of the 
Howard & Joyce Wood Simulation Center. 
“Capstone is one of our success stories.  
The whole school comes together and 
contributes to it,” said Michael M. Awad, MD, 
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A P S T O N E  topics address the curricula 
of modern medicine — patient safety, 
emergency management, end-of-life care, 
informed consent, ethics, working in a team, 
communication, and sign-outs and handoffs, 
among many others. In addition, the class gives 
students tips to manage their personal wellness 
(dealing with stress, time management and 
sleep deprivation). 
Rated particularly high among students 
are the “mock page” sessions. Nurses call in a 
scenario, i.e., “the patient had surgery yesterday 
and is now running a fever,” and students are 
forced to think through the next steps. 
Ca p s to n e  s t u d e n t s  recently completed  
pre- and post-course questionnaires assessing 
their ability to handle clinical problems, 
procedures and patient-care tasks. In all 
categories, students rated their abilities 
markedly higher post-course. 
“The thing many of us felt the most 
apprehension about was getting that call in  
the middle of the night about a patient who 
wasn’t doing well,” said Linda Jin, MD, now a 
first-year surgical resident at Barnes-Jewish 
Hospital. “Even through fourth year, most of 
our education is focused on understanding 
pathophysiology and knowing what is in  
the literature. 
“Capstone helped us synthesize our 
knowledge so we can apply it in a practical 
way. It was also so useful to have a forum to 
practice saying things like ‘I’d like a chest X-ray, 
CBC and BMP now’ in a safe environment.  
One week into my intern year, I said those  
exact things. I’m glad I had a chance to do a 
practice run.”                               
    — Deb Parker
Autumn 201412  Washington University School of Medicine
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difficult to see, even under high magnification. 
Until now, it’s been nearly impossible for operating 
surgeons — using only static MRIs and X-rays as a 
guide — to tell where the tumor ends and healthy 
tissue begins. 
After hearing a group of doctors discuss  
this frustration in 2009, Samuel Achilefu, PhD,  
a professor of radiology at the School of Medicine, 
had an idea: Could night-vision goggles used by 
the military also work in the war against cancer? 
Achilefu’s mission was to design wearable 
technology for surgeons, helping them 
distinguish cancer cells from healthy cells in real time 
— perhaps reducing the need for additional surgeries 
and subsequent stress on patients.
Ability to see glowing cancer cells opens doors  
to precision treatments   B Y  J I M  G O O D W I N
Outlook  15
The goggles evolved from an effective 
but clunky prototype (left), into a 
more streamlined version for testing 
in the O.R. (middle). The version 
currently in development (right) 
provides a clear view of the surgical 
field and the ability to visualize 
cancer cells (highlighted here in 
orange).  The goggles are modeled 
by Suman Mondal, a PhD candidate 
in biomedical engineering, who is 
coordinating research efforts toward 
clinical translation of the technology.
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Removing a tumor and minimal surrounding 
tissue is rarely straightforward; typically  
the exact boundaries are unclear.
Researchers have developed dye agents  
that can pass through healthy cells but  
remain trapped within cancer cells.
T U M O R T U M O R
Targeting cancer
To care for patients, surgeons today remove the tumor 
and neighboring tissue, which may or may not include  
cancer cells. e samples are sent to a pathology lab and 
viewed under a microscope. If the surrounding tissue  
contains cancer cells, a second surgery is performed to 
remove even more tissue, which also is checked for the 
presence of cancer. About 20 to 25 percent of breast cancer 
patients who have lumps removed require a second surgery. 
It’s a balancing act — surgeons don’t want to remove too 
much or too little surrounding tissue.
 “No one wants unnecessary surgery — not surgeons,  
not nurses and certainly not patients or their families,”  
said Achilefu, also a professor of biochemistry and molecular 
biophysics and biomedical engineering. “Our goal with  
these glasses is to eliminate follow-up surgery by removing 
all cancerous cells the rst time.”
Technology U N V E I L E D
Achilefu dedicated ve years to the project. Initially,  
people were skeptical that his idea could be realized. He 
carried out his research using discretionary funds from the 
Mallinckrodt Institute of Radiology and support from the 
Department of Defense Breast Cancer Research Program. 
Achilefu assembled a multidisciplinary team, including engi-
neers and video game specialists, who worked together to 
further rene and miniaturize the glasses. Over time, Achilefu 
successfully demonstrated the technology in mice, rats and 
rabbits, and, in 2012, the team received a $2.8 million grant 
from the National Institutes of Health (NIH). 
Major collaborators include Viktor Gruev, PhD, associ-
ate professor of computer science and engineering, and Ron 
Liang, PhD, associate professor of optical sciences at the 
University of Arizona (UA). Washington University graduate 
students Suman Mondal, Shengkui Gao and Yang Liu and 
UA postdoctoral fellow Nan Zhu also played key roles. 
On Feb. 10, 2014, the high-tech glasses were used during 
surgery for the rst time at the Alvin J. Siteman Cancer Center 
at Barnes-Jewish Hospital and Washington University School 
of Medicine. Surgeon Julie Margenthaler, MD, operated on 
67-year-old breast cancer patient Karen Clodfelter. 
In this procedure, an FDA-approved, commonly used con-
trast agent, indocyanine green, was injected into the patient’s 
tumor. When viewed with near-infrared light, the cancerous 
cells glowed blue. Lighter shades of blue indicated higher 
concentrations of cancer cells. 
Margenthaler was heartened by 
the technology, which enabled her to 
see the tumor, as well as the border-
ing malignant cells. (Tumors gener-
ally do not form in perfect circles, 
but instead have tentacles that  
branch out in dierent directions.)
“We’re certainly encouraged by 
the potential benets for patients,” 
said Margenthaler, an associate professor of surgery at 
the School of Medicine. “Imagine what it would mean if 
these glasses eliminated the need for follow-up surgery 
and the associated pain, inconvenience and anxiety.” 
So far the technology only has been used on 
patients with breast or skin cancer. Given the success 
of the initial nine surgeries — four breast and ve 
melanoma — more are planned. 
“e distinction between normal and cancerous tissue is 
not always clear to the naked eye,” said melanoma surgeon 
Ryan Fields, MD, a Washington University assistant professor 
of surgery who also has used the goggles. “Oen, we’re relying 
on how something looks or feels. Even CT scans and MRI 
images can fail to detect microscopic cancer.”
In a study published in the Journal of Biomedical Optics, 
researchers noted that tumors as small as 1 mm in diameter 
(the thickness of about 10 sheets of paper) can be detected.
V I S I O NC a n c e r
As the dye fluoresces in infrared energy,  
the goggles aid in seeing the boundary 
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eoretically, the technology could be used to visualize 
any type of cancer in the operating room.
Video components in the glasses allow surgeries to be 
recorded. As only a small number of observing medical  
students can t into an operating room, the recordings could 
serve as a useful teaching tool in a larger 
auditorium. ere also may be applica-
tions that could help guide physicians 
practicing in remote areas. 
Achilefu has worked with 
Washington University’s Oce of 
Technology Management and has a  
patent pending for the technology. 
Revolutionizing T R E AT M E N T
Achilefu, who also is co-leader of the 
Oncologic Imaging Program at Siteman 
Cancer Center, is seeking FDA approval 
for a markedly improved contrast  
agent, LS301, he is helping develop.  
is agent, injected into the blood-
stream, selectively enters cancer cells 
anywhere in the body and stays there 
longer, up to a week, in some cases.  
It appears to be the rst contrast agent to mark cancer  
cells universally — breast, prostate, liver, brain, colon,  
leukemia and lymphoid cancers, even metastatic cells.  
e cells glow under infrared light.
Achilefu is optimistic — pending FDA approval for a  
pilot study — that human clinical  
trials will begin soon. For now, his 
research group — partnering in a 
study with the University of Missouri 
School of Veterinary Medicine —  
will be removing cancerous tumors  
in dogs, providing treatment hope for  
the pets’ owners. 
If approved for use in humans, this 
targeted agent potentially could some-
day act not only as a marker, but also  
as a way to deliver drugs directly to 
cancer cells, sparing healthy tissue and 
eliminating some surgeries. e agent 
also may shed light on how tumors  
are responding to chemotherapy.  
Another mission is born.
“Our goal is to make sure no cancer 
is le behind,” Achilefu said.
Future targets
Success of the cancer targeting agents could 
lead to further innovations. For example, 
it might be possible to inject the targeting 
agent along with a cancer therapy, thereby 
identifying and destroying cancer cells even 
before tumor development begins.
The ongoing refinement of the goggles, shown in their latest concept (left), involves cross-disciplinary 
scientific collaboration. Some of the project contributors are pictured here, from left: Ron Liang, PhD,  
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The Human Connectome
Effort to relate brain connectivity to individual capabilities will establish a new baseline for future studies
W H A T  M A K E S  U S  T H I N K ,  F E E L  A N D  R E M E M B E R ?  
Why do people behave differently or have varied learning styles? 
What makes people unique? The answers can be found in the  
neural networks firing within our brains.
The Human Connectome Project (HCP) is a $30-million, five-year 
effort to comprehensively map human brain circuitry — and its 
variability — in 1,200 healthy adults using advanced, noninvasive 
neuroimaging methods. Washington University, the University  
of Minnesota and Oxford University are leading a 10-institution 
consortium involving more than 100 investigators and staff.
The project is gathering and analyzing data, and making its
results freely available to the scientific community, in the hope 
of sparking future discoveries — shedding light on healthy brain 
function and, ultimately, informing doctors’ ability to diagnose and 
treat disorders, such as ADHD, schizophrenia, Alzheimer’s, autism 
and many others. 
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The Human Connectome
Effort to relate brain connectivity to individual capabilities will establish a new baseline for future studies
B Y  M I C H A E L  C .  P U R D YIt took centuries to arrive at today’s detailed views of Earth 
as speculative imaginings yielded to exploration and technology. 
While cartographers only had one Earth to map, HCP collaborators 
are creating maps that may be useful in understanding billions 
of human brains. Researchers are exploring the similarities and 
differences that make us who we are, giving us all our unique mix  
of personality quirks, mental traits and individual identities. 
In short, the HCP is conducting the most complex and ambitious 
mapping ever attempted: charting the intricacies of the living,  
working human brain. Co-principal investigator David Van Essen, 
PhD, appreciates the challenges as well as the limits of this  
historic endeavor.
“In comparison with our historical efforts to chart the Earth’s 
surface, the HCP will, in effect, take us from an 18th-century 
representation of the cortical landscape to a 19th-century 
representation,” Van Essen said.
P R O J E C T E D  D A T A S E T  
1 petabyte
E Q U I V A L E N T  T O 
1 million gigabytes, or
58,000 DVD movies
Open access   
Freely available worldwide
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 The outer cerebral cortex (gray), occupies about 80% of brain 
volume but contains only about 20% of the brain’s 85 billion neurons.  
Its convoluted surface has 150–200 critical areas of study, which  
vary in size twofold or more across the normal adult population. 
 Some 80% of the neurons reside in the cerebellar cortex (gold).  
This region of the brain also varies highly among individuals.
 Subcortical structures (blue) occupy the remaining approximately 
10% of brain volume but contain only about 1% of the neurons. 
 
Understanding complexity  Scientists admit the human brain 
remains a mystery. Each human brain, weighing about 3 
pounds, contains about 85 billion neurons, or nerve cells  
— more than 12 times the number of people on Earth — 
which transmit information across roughly 150 trillion cell-
to-cell connections known as synapses. In nearly all brain 
disorders, there’s something wrong with these connections, 
though, in most cases, scientists don’t yet know exactly  
what has gone awry.
In the last two decades, an explosion of new brain imaging 







Functional magnetic resonance imaging (fMRI), developed 
in the 1990s, opened the door to direct observation of cognitive 
activities. By detecting changes in blood oxygenation and 
ow, fMRI produces activation maps showing which parts  
of the brain are involved in specic mental processes. Using 
fMRI, researchers are scanning participants while they  
perform tasks and at rest.
Diusion MRI gives insight into how regions of the brain 
are physically wired together into networks that communi-
cate electrical signals through the white matter.
Structural MRI scans clearly show the physical features 
of the participants’ brains; these features vary greatly among 
individuals.
See “Making connections” on page 21 to learn more about 
how HCP data is being gathered from the human test subjects.
Wrinkles unraveled   Much of the brain’s uniqueness is found 
in the cerebral cortex, the wrinkled outer layer of the brain 
oen known as the gray matter.
“e cortex is like a sheet that is crumpled and folded up to 
t inside the skull,” Van Essen explained. “is folding pattern 
varies from one person to another, and that makes it really 
hard to just look at a brain and say, ‘okay, how is it organized?’”
Scientists already knew that the wrinkles, or folding  
patterns, of the cerebral cortex are what they call “partially 
heritable.” A glance at the brains of a pair of twins reveals 
major dierences, but closer study uncovers structural  
elements that strongly suggest common genetic inuences.  
Prior to the Connectome, Van Essen was a leader in the 
application of visualization techniques that eectively inate 
the crumpled sheet into a spherical beach ball, making it easier 
to match up signicant features from one brain to the next.
rough the advanced scanning and data-analysis tech-
niques developed and applied by HCP, scientists have created 
another tool for standardizing these comparisons: maps of 
myelin, the protective white material that wraps many nerve 
cell branches. Connectome scientists devised ways to use 
aspects of this material like the mountains, rivers and other 
landmarks that helped earthly mapmakers get their bearings.
Left and right hemispheres
Holding bookends that model the human brain: 
Washington University HCP lead investigators 
Deanna Barch, PhD, the Gregory B. Couch Professor 
of Psychiatry and chair of the Department of 
Psychology, and David Van Essen, PhD, the Alumni  
Endowed Professor of Neurobiology. The HCP’s  
co-principal investigators are Van Essen and  









Why this study is so challenging
Researchers seek to interpret data with respect to the human brain’s 
organizational features and structural dimensions. However, the size, 
function and connectivity of the parts vary so greatly among individuals 
that making comparisons and establishing averages becomes a key 
challenge. Each critical area may connect with dozens of other areas  
and the connection strengths differ over many orders of magnitude.
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CP researchers are studying twins and their non- 
twin siblings, a total of 1,200 subjects, to better  
understand how genes affect the wiring of the brain: 
What aspects of circuitry are inherited and what aspects are 
shaped by experience? 
To reflect the true normal range of brain connections, 
study volunteers come from all racial, ethnic, economic  
and educational backgrounds.
Study volunteers spend about four hours over two days 
in a customized MRI, sometimes lying quietly and sometimes 
performing tasks. All the while, the machine is recording 
patterns of brain activity. A participant might move her right 
hand, for instance, and a section of the left motor cortex 
lights up. The testing is replicated in hundreds of subjects. 
For something more complicated, such as a working 
memory test, several brain regions in the front  
and back light up together, working in a coordinated way. 
“We are trying to understand which parts of brains  
are active when people are processing information,  
doing math or remembering things,” explained Deanna 
Barch, PhD, lead investigator, who is coordinating data 
collection at Washington University. 
In addition to the brain scans, research volunteers undergo 
a battery of cognitive, physical fitness and psychological 
tests. They spend about six hours participating in wide-
ranging activities — from tasting mysterious liquids on a 
cotton swab to running around traffic cones in a corridor. 
These tests, which look at intelligence, sensory abilities 
and emotional state, among other aspects, bring added 
dimension to the imaging data. For instance, do differences  
in brain circuits have any bearing on high or low IQ?
Making connections
Tucker Hartley and Owen Footer, HCP research assistants, perform  
some behavioral tasks used by the HCP to measure each subject’s abilities, 
such as gait speed (top), odor identification (middle), and taste (bottom). 
At right, Footer prepares Hartley for a functional MRI scan in which the 
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“We think there are about 150 to 200 cortical areas — 
analogous to the political subdivisions of Earth’s surface 
— that are critically important for understanding brain 
function and connectivity,” Van Essen said. “Myelin maps 
give us markers for an interesting subset of this mosaic of 
areas. We can see these markers in individual subjects and 
watch how their location jumps around from one subject  
to the next.”
One of Van Essen’s MD/PhD students, Matthew Glasser, 
is leading an eort to create a new master map of the cortex 
based on combining myelin maps with other HCP data.  
ey expect to unveil the map this year.
Future implications  HCP scientists made their fourth large 
data release earlier this year, doubling the data they have 
made available to the public. 
e release included scanning, demographic and 
behavioral data from more than 500 subjects. e infor-
mation is organized in a web-accessible database called 
ConnectomeDB. A soware application, Connectome 
Workbench, allows users to view and compare many types of 
imaging data, both produced by HCP and by other labs.
“ese maps are going to have a major impact on our 
understanding of the healthy adult human brain, and that 
impact is already starting to be felt,” Van Essen, said. “Not 
only have we published many papers on what we’re learning 
about the brain from the data-gathering process, there also 
already have been a handful of independent investigators 
who have published papers based on HCP data. We weren’t 
expecting that this early in the process.
“We’re approaching the point where we have enough  
data to really sink our teeth into these questions and are 
starting to do some serious science on what factors inuence 
the folding of the cortex,” he said.
Lead investigator Barch said that to comprehend how 
structural or functional connectivity goes awry, researchers 
must rst establish the parameters of normal connectivity.
“You need a baseline to work from,” she said. “Down 
the road, the HCP will become a benchmark enabling us to 
see how abnormalities contribute to or result from disease. 
It will suggest better ideas about disease prevention or the 
means of early intervention.”
The ‘state’ of the art in brain mapping
Imagine mapping population centers  
by tracking telecommunications activity — 
say, grouping at least 100,000 phone calls 
from one location to another. This would 
reveal Kansas City and St. Louis as two hot 
spots in Missouri, but would not identify 
individual callers. HCP mapping, somewhat 
similarly, monitors the overall activity of 
more than 100,000 neurons at a time. This 
allows researchers to better understand 
the brain’s functional hot spots and their 
connectivity, providing the most detailed and 
accurate whole-brain portrait yet developed.
Population centers  
of individual callers
Regions of activity from 
1,000s of neurons
At rest    Average functional connectivity  
is collected on subjects while at rest in the  
MRI scanner. Yellow regions are functionally
connected to a “seed” location in the right 
hemisphere, whereas regions in blue and purple 
are weakly connected or not connected at all.
Myelin  Red and yellow regions have 
high myelin content compared to other colors. 
Mapping the myelin on the cortex indicates 
functionally distinct brain regions — an 
important step toward understanding how 
brain networks form dynamically to do tasks. 
Story vs. math  Participants are 
asked to listen attentively to either a story or 
a calculation (e.g. “16 minus 5 plus 18 equals”) 
and answer a question about what they 
heard. Stories activate yellow and red regions, 
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   What we can do for
CANTU
The world’s only clinic
explores the science
behind a rare syndrome
B Y  M I C H A E L  C .  P U R D Y
At the Cantu clinic,  
Cole Eggemeyer shows  
he’s got what it takes.
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Dorothy Grange, MD, 
examines Riley Dyck 
during the Cantu clinic.
A major focus of the Cantu syndrome clinic  
has been in-depth study of the cardiovascular 
abnormalities associated with the condition.  
is June marked the second time the clinic was 
held at the St. Louis campus.
Dorothy K. Grange, MD, professor of pediatrics 
in the Division of Genetics and Genomic Medicine, 
created a registry for Cantu syndrome patients; in 
August 2013, she organized the rst clinic, along 
with professor Gautam K. Singh, MD, instructor 
Mark D. Levin, MD, and assistant professor Beth A. 
Kozel, MD, PhD, all in the Department of Pediatrics.
“We’ve been waiting a long time for this,” Rachel 
Lamfers said. “We’re excited to be able to introduce 
Noah to other children with Cantu syndrome, and 
we want to hear the stories of other families who 
have children aected by this condition.”
At the rst clinic, Tracy Buerck-Eggemeyer’s 
son, Cole Eggemeyer, then 12, was fearful of  
having his blood drawn.
“He asked me, ‘Mom, is having my blood drawn 
going to help other people who have Cantu syndrome 
in the future?’” recalled Buerck-Eggemeyer. “When 
I told him yes, he said, ‘I want to do it.’” 
Bench-to-bedside link
e Cantu clinic and collaborative research eorts 
came about when roads coverged for two dierent 
groups at Washington University Medical Center. 
At St. Louis Children’s Hospital, Grange and 
Singh, professor in the Division of Pediatric 
Cardiology, were treating a family with multiple 
cases of Cantu syndrome. e researchers were the 
rst to suggest that Cantu is 
caused by a defect in a potas-
sium channel gene that aects 
the cardiovascular system.
Meanwhile, Colin Nichols, 
PhD, the Carl Cori Professor 
in cell biology and physiology 
and director of the Center for 
Investigation of Membrane 
Excitability Diseases 
(CIMED), had linked potas-
sium channels — openings in 
the surfaces of cells that let in 
charged potassium particles 
— to neonatal diabetes. To understand the role of 
a related channel, he had mutated the underlying 
gene in the cardiovascular system in mice. 
In late 2012, the two groups realized that their 
investigations were linked. e CIMED scientists 
discovered their mice models with mutated  
Connor Dyck
F   or seven years, Randall and Rachel Lamfers struggled to get a diagnosis for 
their son, Noah, who was born prematurely, had 
problems with pulmonary hypertension and needed 
a breathing tube. In November 2013, analysis of 
Noah’s DNA nally gave them a diagnosis: a rare 
condition called Cantu syndrome.
An Internet search quickly led them to 
Washington University. And this summer, the 
Lamfers, who live in South Dakota, 
brought Noah to St. Louis.
In June, researchers 
and physicians at the 
School of Medicine 
and St. Louis 
Children’s 
Hospital hosted 







and support for 
families, who, 
until this time, 
may have never met  
others with the disorder.  
A scientic symposium was held  
in conjunction with the clinic. 
Medical literature reports only about 50  
people with Cantu, but many more now are being 
identied by genetic analysis, and the researchers 
already are following six patients in the St. Louis 
area, indicating that the syndrome may be 
signicantly more common than rst realized.
Cantu syndrome causes excessive hair growth, 
bone abnormalities, swelling in the legs, problems 
with heart function and a range of other symptoms 
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Cantu syndrome can cause heart 
chamber enlargement, low blood 
pressure and fluid build-up. 
Ultrasound provides a detailed view 
of Noah Lamfers’ heart in motion 
(inset). Gautam K. Singh, MD, dis-
cusses the care recommendations 
with Noah’s mother, Rachel.
Hold tight! Colin Nichols, PhD, measures Riley Dyck’s ability to maintain his grip  
for up to two minutes. Such measures will establish a baseline for Riley’s condition 
and allow physicians to accurately gauge future changes and benefits of therapy.
potassium channels had Cantu-like symptoms. At 
about the same time, the clinicians’ genetic studies, 
conducted in collaboration with a group of Dutch 
researchers, led them to a gene called ABCC9. 
“at’s not the same gene we were studying;  
we had mutated a gene called KCNJ8 in our mice,” 
Nichols said. “But we knew that proteins from each 
of these two genes come together to form a single 
potassium channel, and we now know that muta-
tions in either gene can cause Cantu syndrome.”
Due to these mutations, the potassium channels 
remain open, making it harder for blood vessels  
to contract, a step that helps the circulatory system 
increase blood pressure when needed.
CIMED, a BioMed 21 interdisciplinary research 
center, specializes in studying these kinds of 
changes. Problems with these channels can lead to 
neurological and psychological disorders, cardiac 
arrhythmias, cystic brosis, diabetes and myriad 
other conditions. Nichols and the members of 
CIMED — which now include Grange and Singh 
— focus on improving therapies for these diseases.
Moving forward
Nichols said he believes the Cantu group is on 
the verge of signicantly alleviating the marked 
lifestyle and clinical problems from which these 
patients suer, and is gearing up for trials of a  
targeted drug therapy. 
 “Until now, Cantu syndrome patients have 
been treated solely on the basis of their symptoms, 
and what we’re learning now about the actual 
causes of those symptoms suggests that there may 
be better ways to treat them,” Nichols said.
“For example, even before the link to Cantu 
syndrome was identied, we were nding evidence 
that the mutation we were studying in mice causes 
blood vessels to relax,” Nichols added. “at can 
explain why the ductus arteriosus, a vessel that 
redirects blood ow during fetal life, fails to close 
BioMed 21
Dedicated to speeding  
the transformation of  
basic science discoveries 
into advances in the  
clinical diagnosis and 
treatment of disease.  





normally aer birth in many Cantu patients.  
It may also help us nd new ways to close o this 
blood vessel in other situations.” 
Based on what they’ve learned from studying 
Cantu syndrome patients, Washington University 
researchers now know more about how drugs such 
as Rogaine or minoxidil stimulate hair growth.
“Because of the gene mutation they carry,  
these patients are experiencing the equivalent of  
a chronic overdose of minoxidil,” Nichols said. 
e clinic’s discoveries may not only help 
develop appropriate treatments for the cardiovas-
cular problems and excess hair growth seen in 
Cantu and in other conditions, but also aid in the 
search for improved drugs that promote hair growth.
“e advances in our knowledge about Cantu 
syndrome have been incredible in the last two 
years,” Grange said. “I am optimistic we will have 
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A legacy of
gratitude
Breakthroughs in developing leukemia therapies, in treating 
osteoporosis and childhood asthma, in ghting viruses that cause 
blindness, and in understanding Alzheimer’s disease — these and 
countless other advances have come about with the aid of one  
St. Louis couple, the late Alan A. and Edith L. Wol. Together they 
donated more than $70 million to the School of Medicine to ght 
cancer and other diseases and to support the scientists and physicians 
responsible for the medical breakthroughs.
“e power of philanthropy to change people’s lives and improve 
the well-being of future generations is undeniable,” said Chancellor 
Mark S. Wrighton. “Patients here at the Medical Center and around  
the world have beneted from the generosity of supporters such  
as Alan and Edith Wol — through improved patient care, new 
treatments and a deeper understanding of the causes of diseases. 
“rough their gis, which continue to fund the work of world-
renowned physicians and researchers, the Wols have le a lasting 
legacy by advancing medicine and science. In the process they have 
earned the gratitude of us all.”  
e commitment of one family has made a profound dierence.
Thanks to the far-reaching 
vision of the late Alan A. 
and Edith L. Wolff, countless 
lives are changing through 
improved patient care, 
breakthrough research 
and student mentorship. 
The couple’s estate has 
endowed 20 professorships 
in perpetuity at the School 
of Medicine.
Leading Together The Campaign for Washington University
BY  R ICK  SKWIOT
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Alan and Edith Wolff lived a quiet life, according to 
those who knew them, remaining in the same 
unassuming home despite their growing wealth. 
But their dynamic work as civic benefactors and 
philanthropic leaders over the years has helped 
Washington University excel in medical science, 
enabling its researchers and physicians to make 
advances that benet 
patients worldwide and 
continue to propel new, 
life-saving discoveries.  
 e Wols found suc-
cess developing subdivi-
sions and shopping centers 
in Missouri, Illinois and 
Kansas. But they created a 
lasting legacy through their 
eorts to help those in 
need and those striving to 
advance medical care.
“e 20 endowed professorships that the Wols 
have established in perpetuity enable us to recruit 
and retain world-class talent dedicated to continu-
ing our cutting-edge biomedical and translational 
research,” said Larry J. Shapiro, MD, executive 
vice chancellor for medical aairs and dean of  
the School of Medicine.
Aer Alan Wol’s death in 1989, Edith Wol 
took over Wol Construction Co. and its subsid-
iaries, successfully expanding its assets. She also 
expanded the family’s philanthropic eorts.  
In 2007, she made a $20-million commitment  
to Washington University School of Medicine to 
establish the Alan A. and Edith L. Wol Institute, 
underwriting promising biomedical research  
and serving as the principal support for the  
university’s BioMed 21 initiative. Other multi-
million-dollar gis went to fund cancer research 
and to endow an interest-free loan fund for  
medical students. 
Shapiro said that informed, thoughtful and 
targeted philanthropy like the Wols’ signi-
cantly inuences medical science. 
“Such philanthropic support is vital as federal 
research budgets tighten, and at a time when 
we are on the verge of so many new discoveries 
thanks to the explosion of knowledge in  
genetics and molecular biology,” Shapiro said.  
“Our ongoing quest to understand, diagnose  
and treat disease depends in large part on people 
like the Wols.
“e Wols’ impact is immeasurable,”  
Shapiro said.
But in some ways the Wols were unlike many 
other successful people, according to their long-
time attorney James L. Fogle.
“Mr. Wol was particularly quiet about the 
extent of their wealth, and they were rather quiet 
about their generosity as donors when he was 
alive. But then Edith increasingly took a higher-
prole leadership role in order to encourage  
others to give as well,” Fogle said.
“ey didn’t have children. Edith focused on 
helping people who couldn’t take care of them-
selves and to supporting people aspiring to do 
great things,” he said. In addition to medical 
research, many community organizations ben-
etted from Edith Wol’s generosity.
She died in 2008 at age 93.
Although the Wols’ relationship with the 
Medical Center dates back to when Edith, at age 
16, volunteered at the original Jewish Hospital, 
they were rst inspired to support Washington 
University by the late I. Jerome Flance, MD,  
professor emeritus of clinical medicine. 
Flance, a close friend and their personal  
physician for more than 50 years, fueled their 
interest in the medical research being done at  
the School of Medicine and helped guide them  
in their initial contributions to the university. 
“Our ongoing quest to 
understand, diagnose and 
treat disease depends in 
large part on people like 
the Wols.”
— Larry J. Shapiro, MD
From left: Wolff 
Professors Daniel C. 
Brennan, MD; Chyi-Song 
Hsieh, MD, PhD; and 
Daniel S. Ory, MD.
The Wolff legacy endures
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A gallery of Wolff Professors in action — clockwise from top: 
Urologist Arnold D. Bullock, MD, advises a resident in the operating 
room; geriatrician David B. Carr, MD, assesses driving skills in older 
adults; Daniel C. Link, MD, studies the genomics of leukemia; and 
Mario Castro, MD, MPH, listens to the lungs of a patient with asthma.
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The Wolff 
professors
Wolff Professors are leaders in many disciplines 
at the School of Medicine. Following is a list of 
professors and dates of installation. Five more 
professors will be added, bringing the total to 20. 
William A. Peck, MD 
Alan A. and Edith L. Wolff  
Distinguished Professor of Medicine
S E P T .  9 ,  2 0 0 2
Daniel C. Link, MD 
Alan A. and Edith L. Wolff  
Professor of Medicine
J U LY  1 ,  2 0 0 9
L. David Sibley, PhD
Alan A. and Edith L. Wolff Distinguished  
Professor of Molecular Microbiology
A U G .  1 0 ,  2 0 11
Daniel C. Brennan, MD 
Alan A. and Edith L. Wolff  
Professor of Renal Diseases
A U G .  8 ,  2 0 13
Chyi-Song Hsieh, MD, PhD 
Alan A. and Edith L. Wolff  
Professor of Rheumatology
A U G .  13 ,  2 0 13
Daniel S. Ory, MD 
Alan A. and Edith L. Wolff  
Professor of Cardiology
A U G .  15 ,  2 0 13
Lee Ratner, MD, PhD 
Alan A. and Edith L. Wolff  
Professor of Oncology
S E P T .  2 3 ,  2 0 13
Mario Castro, MD, MPH 
Alan A. and Edith L. Wolff Professor of  
Pulmonary and Critical Care Medicine
D E C .  12 ,  2 0 13
Richard K. Wilson, PhD
Alan A. and Edith L. Wolff  
Distinguished Professor of Medicine
M A R C H  2 0 ,  2 0 1 4
Todd P. Margolis, MD, PhD
Alan A. and Edith L. Wolff Distinguished  
Professor of Ophthalmology and Visual Sciences
A P R I L  4 ,  2 0 1 4
Arnold D. Bullock, MD
Alan A. and Edith L. Wolff Distinguished  
Professor of Urology
J U N E  1 8 ,  2 0 1 4
David B. Carr, MD
Alan A. and Edith L. Wolff  
Professor of Geriatric Medicine
A U G .  1 4 ,  2 0 1 4
John Turk, MD, PhD
Alan A. and Edith L. Wolff  
Professor of Endocrinology
S E P T.  4 ,  2 0 1 4
Lilianna “Lila” Solnica-Krezel, PhD
Alan A. and Edith L. Wolff Distinguished  
Professor of Developmental Biology 
N O V .  3 ,  2 0 1 4
Aaron DiAntonio, MD, PhD
Alan A. and Edith L. Wolff  
Professor of Developmental Biology 
D E C .  11 ,  2 0 1 4
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In their own words
Below, in their own words, meet three Alan A. and Edith L. Wol Distinguished 
Professors. ey discuss the role of philanthropy in advancing medical science and 
the impact of the Wol legacy on the School of Medicine. 
“Jerry Flance, a great internist and 
Washington University clinical professor, intro-
duced me to Edith, his patient and close friend  
in the 1990s. I had the privilege of visiting with 
Edith frequently thereaer. When her husband,  
Al, passed away, Edith’s de leadership continued 
to advance his ourishing real estate business.  
Al’s estate included funds to be held for the sup-
port of medical research and Edith was able to use 
her own funds and estate for the same purpose.
“With the advice of Jerry Flance, Edith pro-
ceeded to provide funds for multiple outstanding 
Washington University scientists. Edith had a  
passion for excellence and ‘invested’ accordingly. 
William A. Peck, MD, director 
of the Center for Public Health, 
was the first Wolff Distinguished 
Professor, named in 2002, when 
he served as dean of the School 
of Medicine and executive vice 
chancellor for medical affairs.  
A noted clinician and researcher 
in bone and mineral metabolism, 
he served as founding president 
of the National Osteoporosis 
Foundation.
In addition to supporting the research, Edith’s funds 
have established multiple endowed chairs at our 
institution, enhanced by actual research support.
“Forgetting about me, excellent scientists and 
department heads have been so honored, includ-
ing leaders in a wide variety of missions from  
geriatrics to genomics.
“Edith knew the impact that these investments 
would have over the lasting lifetime of our institu-
tion: support for leadership and research, enabling 
the recruitment and retention of outstanding 
faculty and enhancing their productivity. is 
incredibly creative philanthropy is likely to yield 
an enormous positive impact worldwide.”
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“The amount of NIH [National Institutes of 
Health] support has been shrinking for the past  
15 years. e core modular grant of $250,000 
hasn’t changed, it’s much harder to get a grant, 
and the buying power has decreased dramatically. 
“If a researcher doesn’t get a grant, it takes nine 
months to turn around another submission —  
and so who covers the research in that interim? 
Even the best scientists in the world don’t always 
get the grant, and even if they do, it’s not going  
to cover the costs of research. So the way we need  
to do this is through philanthropy.
“My attitude about philanthropy is this: 
Whenever patients get a good result, they thank 
the physician. But what they are really thanking 
Earlier this year, Todd P. Margolis, 
MD, PhD, was named chair of the 
Department of Ophthalmology 
and Visual Sciences and 
ophthalmologist-in-chief at 
Barnes-Jewish Hospital. Former 
president of the world’s largest 
eye and vision research organiza-
tion, the Association for Research 
in Vision and Ophthalmology,  
his own research focuses on the 
herpes simplex virus and blind-
ness. He was named a Wolff 
Professor in April.
are the physician’s skill and training and the 
research that allowed him or her to use the most 
modern methods — all of which need to be  
supported in one way or another.
“Philanthropy in medicine is absolutely critical. 
Institutions used to be able to make up the money 
from clinical services, but those days are pretty 
much gone. It’s very hard to do that the way insur-
ance has gone and where health care is going.
“Endowed professorships and research funds — 
such as the ones the Wols established — allow 
us to oset some of the costs and recruit the best 
people and allow us to have funding for pilot  
projects and interim funding — bridge funding —  
for individuals, and it gives us some exibility.”
Building excellence  Todd P. Margolis, MD, PhD
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“Philanthropic support for research is  
particularly important currently for many reasons. 
Number one is that we are witnessing an un- 
precedented potential for biomedical sciences 
right now. ere are many technologic break-
throughs that allow us to ask questions that we 
were not able to ask before. ey allow us to study 
diseases and now recognize the genetic codes of 
diseases that we were not able to do previously, 
and not at the rate we can do now. 
“From the perspective of the Department of 
Developmental Biology, there are entire areas  
that relate to adult stem cells and embryonic stem 
cells that really open completely new avenues  
to study and understand birth defects, and to 
study aging and ameliorate the eects of aging. 
We are living in times of absolutely remarkable 
potential for biological sciences.
“We are witnessing nancial limitations because 
federal funding for research is going down in all 
practical terms. is scal tightening in biomedical 
research discourages many young people from 
choosing science as a calling.
“Philanthropic support — such as the two 
endowed professorships in our department — 
becomes more crucial as the only means to 
provide support for imaginative high-risk, high-
potential-payo investigations that can transform 
the way we understand, diagnose and treat disease.
 “Philanthropic support touches our department 
and all departments of Washington University.  
It is truly welcome — and we are so grateful for 
our donors — because it allows us to retain the 
most talented faculty and also allows these faculty 
to have freedom of investigation, to ask the most 
important questions and not be limited by the 
current scal constraints.”
Building excellence  Todd P. Margolis, MD, PhD
Opening new avenues  Lilianna Solnica-Krezel, PhD
Lilianna Solnica-Krezel, PhD, 
head of the Department of 
Developmental Biology,  
will be installed as a Wolff 
Distinguished Professor in 
November. Using advanced 
imaging and genetic 
techniques, she studies 
embryonic development in 
zebrafish models to better 
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classnotes
1940 S 
William Anderson, MD 42, is retired in 
Williamsburg, Va., and enjoys reading and 
attending movies, plays and shows.
Clayton Manry, MD 44, is retired and living 
in Redwood City, Calif. His hobbies include 
gardening and orchid culture.
1950 S 
Irving Kushner, MD 54, is professor emeri-
tus of medicine at Case Western Reserve 
University and served as a medical expert 
for the Social Security disability system. He 
spends his free time writing and reading 
and has published several articles recently.
Richard Aach, MD 59, and his wife are 
happy to have returned to St. Louis. In 
addition to attending Lifelong Learning 
Institute classes through University 
College, Aach enjoys photography, gar-
dening and visiting the Saint Louis Art 
Museum. He was inducted into Clayton 
High School’s Alumni Hall of Fame in May.
1960 S 
Gabriel Zatlin, MD 60, has retired from 
patient care and teaching medical stu-
dents and residents. He and his wife, 
Jan, now enjoy spending time at their 
Connecticut home, watching the fauna 
and growing vegetables.
John Bigger, MD 64, is an active volunteer 
with local arts groups in South Carolina, 
including serving as president of the 
North Augusta Arts Council and as trea-
surer of the Arts and Heritage Center. He 
and his wife have 12 grandchildren.
1970 S 
James Hudson, MD 75, was the 2013 recipi-
ent of Alton Memorial Hospital’s presti-
gious Chairman’s Award. After more than 
34 years, he has retired from the practice 
of ophthalmology in Alton, Ill., and now 
enjoys spending time with his four young 
grandsons.
Pamela McLain, MD 77, is symposium 
director for the North American Young 
Rheumatology Investigator Forum. Now in 
its eighth year, the forum promotes men-
toring and networking with rheumatology 
fellows across North America. She is proud 
to note that fellows from Washington 
University have attended, presented their 
research and been given the best abstract 
award. 
1980 S 
Chandlee Dickey, MD 89, is director of the 
Harvard South Shore Psychiatry Residency 
Training Program and assistant professor 
at Harvard Medical School. Since switching 
into education, she enjoys mentoring the 
residents and creating innovative teaching 
experiences.
Ellen Reynolds, MD 89, is medical director 
of the Department of Children’s Surgery at 
St. Luke’s Regional Medical Center in Boise, 
Idaho. In her free time, she is a swimmer, 
and holds national and world records 
for her age group with U.S. Masters 
Swimming.
1990 S 
Melissa Piasecki, MD 91, is the senior  
associate dean for academic affairs and a 
professor of psychiatry at the University  
of Nevada School of Medicine.
Grant Hoekzema, MD 94, was named 
chair of the Council of Academic Family 
Medicine for 2013-14. He recently com-
pleted a three-year term as president 
of the Association of Family Medicine 
Residency Directors. Hoekzema is program 
director for Mercy Family Medicine in  
St. Louis.
2000 S
Kenisha Campbell, MD 04, is assistant 
professor of pediatrics, medical direc-
tor of Adolescent Primary Care & Family 
Planning Services, and co-director of 
Adolescent Medicine Outpatient Rotation 
at Children’s Hospital of Philadelphia.  
She enjoys spending time with her son, 
staying active at the gym and playing 
tennis.
Elliott Weiss, MD 10, has been selected 
for the Penn Fellowship in Advanced 
Biomedical Ethics. He will work toward a 
Master of Science in Medical Ethics at the 
University of Pennsylvania while continu-
ing his neonatology fellowship at the 
Children’s Hospital of Philadelphia.
In Memory 
Rebecca Kay Acquisto, OT 99
 Acquisto, 55, of Longmont, Colo., died 
Saturday, April 5, 2014, at the age of 55 
from complications of a brain tumor. She 
attended Texas Women’s University, where 
she graduated with honors before receiv-
ing a master’s degree from Washington 
University. In her free time, Acquisto 
enjoyed beekeeping, backpacking, water-
color painting, gardening and knitting. 
Through her work and her personal life, 
she loved helping people, cherished her 
friendships and will be dearly missed. She 
mentored and supported many women 
over her lifetime. 
Karen Arnold, MD 68, HS 69
 Arnold, 72, of Mechanicsburg, Pa., and 
formerly of St. Louis and Belleville, Ill., died 
Monday, April 28, 2014. After attending 
the University of Notre Dame and receiv-
ing a medical degree from Washington 
University, Arnold proudly served in the 
U.S. Air Force as a physician. Afterward she 
returned to St. Louis where she was a gen-
eral and vascular surgeon before retiring 
in 2002. Arnold then worked at FairCode 
Associates for more than eight years until 
her death. She was a faithful member of 
Saint Katharine Drexel Catholic Church 
where she served on the Women’s Council 
and attended daily Mass. 
Terrell Covington Jr., LA 40, MD 43
 Covington died Sunday, April 13, 2014, 
at 95. After graduating from WUSM, 
he undertook a rotating internship as 
a second lieutenant in the U.S. Army 
Corps, eventually training as an officer 
following World War II. He went to North 
Autumn 201434  Washington University School of Medicine
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Carolina to serve as a ward physician of a 
1,200-bed temporary hospital overseen 
by the Jefferson Medical College treat-
ing the sick and injured soldiers from the 
Pacific Theatre. After nine months, he was 
transferred to Fort Belvoir in Virginia and 
became chief of medicine and headed 
the dispensary. In 1950, Covington moved 
to Tulsa where he dedicated his life to 
community development and projects 
related to health-care needs. He practiced 
at St. John Hospital for almost 50 years 
where he became chief of staff in 1971. 
Covington retired at the age of 80. He was 
very proud to watch his granddaughters, 
Emily, LA 12, and Anna, LA 12, receive 
their white coats in August 2013 as they 
began as WUSM students.
Eugene Crews III, MD 70, HS 74
 Crews, of Atlanta, died Sunday, Feb. 23, 
2014. He earned a medical degree and 
completed a psychiatric residency at 
WUSM. After service in the U.S. Navy, he 
was associate professor of psychiatry at 
the University of Alabama in Birmingham 
(UAB) and director of UAB Psychiatric 
Residency Training. Crews was inducted 
into the Missouri Athletic Hall of Fame 
in 1962 for shot put as a University City 
High School senior. He also was a Mystical 
Seven scholar-athlete at the University of 
Missouri-Columbia and inducted into its 
Hall of Fame in 2000.
Paul Cummings, MD 93
 Cummings, of Portland, Ore., died 
Thursday, Feb. 13, 2014, of gastric cancer. 
He attended Willamette University study-
ing science, math and humanities before 
pursuing training as a physician. After 
completing a medical degree, Cummings 
was awarded a fellowship at the University 
of Witwatersrand in South Africa, practic-
ing both rural and inner-city medicine. 
He then completed an internal medicine 
residency at the University of Washington 
in Seattle. Cummings later worked for 
Legacy Health and focused on effective 
and best practices for patient care. He is 
remembered for his love of the outdoors, 
strong sense of family and one of his 
favorite sayings: “solvitur ambulando”  
(it is solved by walking).
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Jack F. McKemie, MD 43
 McKemie died Monday, April 29, 2013, 
at 95. After graduating from WUSM, he 
completed an internship at Barnes-Jewish 
Hospital and a residency at Children’s 
Medical Center in Dallas before serving in 
the U.S. Army. He was a longtime pediatri-
cian, first serving in Corpus Christi, Texas, 
and then at the Santa Rosa Hospital emer-
gency room in San Antonio.
Charles Miller Jr., MD 52
 Miller died Saturday, Oct. 19, 2013. After 
graduating from Washington University, 
he proudly served the Kirkwood commu-
nity as a physician for 42 years.
Richard H. Morrow Jr., MD 58
 Morrow of Baltimore died Saturday, 
Aug. 17, 2013, at 81 from pancreatic 
cancer. A professor in the Johns Hopkins 
Bloomberg School of Public Health since 
1991, Morrow was a pioneer in the field of 
international public health. Prior to joining 
Hopkins, he established public health pro-
grams in Africa, taught at Harvard School 
of Public Health, and directed a tropical 
disease program at the World Health 
Organization in Geneva, Switzerland. He 
earned a bachelor’s degree in econom-
ics from Swarthmore College, a medical 
degree from WUSM and a master’s degree 
in public health from Harvard University. 
Morrow completed a residency at the 
Strong Memorial Hospital in Rochester, 
N.Y. He received the 2006 Lifetime 
Achievement Award from the American 
Public Health Association’s International 
Health Section. 
C. Barber Mueller, MD 42
 Mueller died Thursday, Feb. 13, 2014,  
after a brief illness. He attended Blackburn 
College, graduated from the University  
of Illinois and received medical education 
at Washington University. He was a 
decorated World War II veteran, having 
served in the South Pacific. Mueller was 
in the first class of Markle Scholars, a 
Distinguished Fellow of the American 
College of Surgeons and chairman of 
surgery at the Upstate Medical Center  
in Syracuse, N.Y. Additionally, he was the 
founding chairman of the Department 
of Surgery at McMaster Medical Centre, 
and was always devoted to the cause of 
medical education.
David W. Talmage, MD 44
 Talmage died Thursday, March 6, 2014, at 
the age of 94. Born in Korea to missionar-
ies and spending his young life there, 
Talmage came to the U.S. and graduated 
from Davidson College in 1941 before 
attending Washington University for 
medical school. From 1945–47, he served 
as a medical adviser to the Korean gov-
ernment for the U.S. Army. He later served 
two internships, one at Georgia Baptist 
Hospital and the other at Barnes Hospital 
where he then completed a residency 
and fellowships between 1949 and 1951. 
Talmage had a distinguished career at the 
University of Colorado Health Sciences 
Center (UCHSC), the University of Chicago 
and the University of Pittsburgh. He 
served in many roles at these institutions, 
including professor, department chair-
man, associate dean of research affairs 
and dean of the faculty at UCHSC. He 
was elected to the National Academy of 
Sciences in 1976. Other awards include 
the Bonfils-Stanton Foundation Award, 
the Sandoz Prize for Immunology and two 
honorary Doctor of Science degrees. He 
also was a member of Phi Beta Kappa and 
Alpha Omega Alpha.
Ljubinka “Louise” Vojcanin, NU 50
 Vojcanin died Thursday, March 6, 2014, at 
86. Born in St. Louis, she graduated from 
Cleveland High School before attend-
ing the Washington University School of 
Nursing. Vojcanin served as a registered 
nurse at Barnes Hospital, Anheuser-Busch, 
Holy Cross Hospital, Nabisco Brands 
and in private practice. She was a past 
president of Holy Trinity Orthodox Church 
Choir, national secretary and historian of 
the Federation of Serbian Sisters Circles, 
and member of the Sisters Circles of 
the Myrrh-bearing Women of St. Sava 
Monastery, St. George (Schereville),  
St. John the Baptist (Bellwood), and  
Holy Trinity (St. Louis).
If you wish to make a tribute gift in honor  
of any of the above alumni or faculty, please 
contact: Pamela Buell, Washington University 
Medical Alumni and Development, Campus Box 
1247, 7425 Forsyth Blvd., Suite 2100, St. Louis MO 
63105-2161, (314) 935-9691.
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Together, we can change lives!
For information on supporting the School of Medicine 
through an outright gift, contact:
Pamela Buell, Associate Vice Chancellor for  
Medical Alumni and Development 
(314) 935-9698    email: meddev@wustl.edu 
 
Consult with your legal or tax adviser before making a charitable gift.
Planned giving benefits include:
n Significant charitable deductions
n Capital gain tax benefits
n Estate tax benefits
n Lifetime payments to you and/or loved ones
To learn how you can make a planned gift,  
contact the Oce of Planned Giving:
(800) 835-3503 or (314) 935-5373
plannedgiving.wustl.edu
Thank you to the many alumni and friends  
who have supported Leading Together: The 
Campaign for Washington University through an 
estate gift, life income plan or other planned gift.     
      Countless individuals will benefit from the life-
changing impact of the scholarships, professorships, 
research and clinical care these gifts will fund. 
Planned gifts shape the School of Medicine, from 
endowed scholarships, such as the Jackson Johnson 
Scholars, to innovative research centers, including  
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No small achievement
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Four-year-old Ian Rimer accepts a medical degree on 
behalf of his dad, Ryan, from Dean Larry J. Shapiro, MD, 
during the May 15 Commencement ceremony. Ryan,  
who has wanted to be a physician since he was 10, 
earned his long-awaited degree after previously working 
as a Nevada firefighter-paramedic. He remains in St. Louis 
for a diagnostic radiology residency at Barnes-Jewish 
Hospital. A father of four, he is married to Jamie Rimer,  
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The Ellen S. Clark Hope Plaza re-creates a Missouri woodland, with an infinity fountain as a serene centerpiece. A new, mobile-
friendly website offers a guide to the medical campus’s central green space. Discover the concept behind the plaza’s design, 
locate and identify plants and explore growth details provided by the Missouri Botanical Garden: hopeplaza.wustl.edu
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